Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

Clinical trial NCT05957653 · UNKNOWN

Trial details

NCT number: NCT05957653
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-10-07
Primary completion: 2025-09-30
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.